APOB

gene product
This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
1050 antibodies from 38 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
310 antibodies
GeneTex
19 antibodies
Novus Biologicals
29 antibodies
Abnova Corporation
27 antibodies
Biorbyt
38 antibodies
Acris Antibodies GmbH
33 antibodies
OriGene
25 antibodies
Invitrogen Antibodies
19 antibodies
NovoPro Bioscience Inc.
9 antibodies
R&D Systems
6 antibodies
Affinity Biosciences
2 antibodies
Atlas Antibodies
1 antibody
LifeSpan BioSciences, Inc.
313 antibodies
Proteintech Group
1 antibody
St John's Laboratory
4 antibodies
NSJ Bioreagents
3 antibodies
Boster Biological Technology
2 antibodies
Aviva Systems Biology
10 antibodies
Abgent
8 antibodies
Creative Biolabs
66 antibodies